Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-02-13 | 2018-09-10 | 39656 |
APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-03-27 | 2018-09-11 | 44105 |
APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-05-15 | 2018-09-15 | 49493 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-07-15 | 2018-09-15 | 55807 |
APO-LOXAPINE | 5MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19075 |
APO-LOXAPINE | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19078 |
APO-LOXAPINE | 25MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19081 |
APO-LOXAPINE | 50MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19084 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2017-04-07 | 2017-05-18 | 5997 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2017-06-28 | 2017-10-27 | 14186 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2017-10-03 | 2017-11-02 | 24268 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2020-07-29 | 2020-08-05 | 121331 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2020-09-09 | 2020-12-07 | 123944 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140069 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2021-08-27 | 2022-01-31 | 144662 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147302 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2022-07-22 | 2022-08-12 | 165326 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2023-01-13 | 2024-03-22 | 181101 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189671 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2023-09-01 | 2023-12-22 | 203557 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |
APO-VORICONAZOLE | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60861 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |